B. Riley Wealth Advisors Inc. Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

B. Riley Wealth Advisors Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 42.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 6,783 shares of the financial services provider’s stock after selling 4,939 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $975,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at $36,000. Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $59,000. Finally, Aptus Capital Advisors LLC increased its position in shares of iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after purchasing an additional 114 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $137.66 on Wednesday. The business has a 50-day moving average price of $141.74 and a 200 day moving average price of $142.40. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which will be paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th will be given a dividend of $0.0624 per share. The ex-dividend date of this dividend is Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.